Tetrahydrocannabivarin

From Self-sufficiency
Revision as of 18:46, 13 July 2010 by Citation bot 1 (Talk) (Citations: [Pu173] added: pmc. You can use this bot yourself! Report bugs here.)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Tetrahydrocannabivarin
File:Thcv.svg
File:Tetrahydrocannabivarin-3D-balls.png
Systematic (IUPAC) name
6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
Clinical data
Routes of
administration
Oral, Smoked, Inhaled
Legal status
Legal status
  •  ?
Identifiers
CAS Number 28172-17-0
ATC code none
PubChem CID 34180
ChemSpider 31500
Chemical data
Formula C19H26O2
Molar mass 286.41 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tetrahydrocannabivarin (THCV, THV), also known as tetrahydrocannabivarol, is a psychoactive cannabinoid found naturally in Cannabis sativa. It is an analogue of tetrahydrocannabinol (THC) with the sidechain shortened by two CH2 groups. THCV can be used as a marker compound to differentiate between the consumption of hemp products and synthetic THC (e.g., Marinol).

Natural occurrence

THCV is found in largest quantities in Cannabis sativa subsp. indica strains. Some varieties that produce propyl cannabinoids in significant amounts, over five percent of total cannabinoids, have been found in plants from South Africa, Nigeria, Afghanistan, India, Pakistan and Nepal with THCV as high as 53.69% of total cannabinoids.[1] They usually have moderate to high levels of both THC and Cannabidiol (CBD) and hence have a complex cannabinoid chemistry representing some of the world's most exotic cannabis varieties.[2]

Pharmaceutical properties

It has been shown to be a CB1 receptor antagonist, i.e. blocks the effects of THC.[3] In 2007 GW Pharmaceuticals announced that THCV is safe in humans in a clinical trial and it will continue to develop THCV as a potential cannabinoid treatment for type 2 diabetes and related metabolic disorders, similar to the CB1 receptor antagonist rimonabant.[4]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links


fr:Tétrahydrocannabivarine

it:Tetraidrocannabivarina hu:Tetrahidrokannabivarin pl:Tetrahydrokannabivarin

ru:Тетрагидроканнабиварин
  1. Turner, C.E., Hadley, K.W., and Fetterman, P. 1973. Constituents of Cannabis Sativa L., VI: Propyl Homologues in Samples of Known Geographical Origin. J. Pharm. Sci. 62(10):1739-1741
  2. Deluxe Marijuana Grower's Guide, by Mel Frank [revised edition 1997] pg.37
  3. Pertwee RG, Thomas A, Stevenson LA; et al. (2007). "The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo". Br. J. Pharmacol. 150 (5): 586–94. doi:10.1038/sj.bjp.0707124. PMC 2189766Freely accessible. PMID 17245367. 
  4. Press Release by GW Pharmaceuticals[1]